Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
63.2M
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
23.1M
-
Shares change
-
+2.74M
-
Total reported value, excl. options
-
$331M
-
Value change
-
+$38.3M
-
Put/Call ratio
-
0
-
Number of buys
-
46
-
Number of sells
-
-25
-
Price
-
$14.34
Significant Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q2 2022
91 filings reported holding TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value as of Q2 2022.
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.1M shares
of 63.2M outstanding shares and own 36.49% of the company stock.
Largest 10 shareholders include ALLIANCEBERNSTEIN L.P. (3.3M shares), VANGUARD GROUP INC (2.93M shares), BlackRock Inc. (1.84M shares), NEXT CENTURY GROWTH INVESTORS LLC (1.74M shares), CIBC Private Wealth Group, LLC (1.14M shares), EMERALD ADVISERS, LLC (1.07M shares), PERCEPTIVE ADVISORS LLC (941K shares), EMERALD MUTUAL FUND ADVISERS TRUST (930K shares), TimesSquare Capital Management, LLC (873K shares), and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (819K shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.